QIAGEN Buys Synthetic Nucleic Acid Company.(Brief Article) From: Instrument Business Outlook | Date: June 15, 2000 | COPYRIGHT 2000 Strategic Directions International Inc. (SDI). This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Venlo, Netherlands 6/12/00-QIAGEN N.V. announced it will acquire Operon Technologies, the leading US synthetic nucleic acid producer for $110 million. Operon also manufactures synthetic full-length genes and DNA microrrays using high-throughput DNA synthesis technology. Synthetic nucleic acids are used in the analysis of nucleic acid samples with unknown sequences and in virtually every genomic and genetic analysis technique. In fiscal year 1999, Operon had over $13 million in re...